Europe took a decisive step toward pharmaceutical sovereignty on January 21, when the European Parliament overwhelmingly approved the Critical Medicines Act. With 503 MEPs backing the proposal out of 668, the legislation now enters trilogue negotiations (three-way talks between Parliament,
“Despite the volatility, the industry is getting some positive energy and renewed confidence” Jeremie Trochu, Chief Executive Officer at Ardena, has spent two decades building and scaling businesses across the biopharma sector. He was part of the leadership team that
Resilience Government Services, a subsidiary of National Resilience, has secured approximately $17.5 million in funding to bolster domestic manufacturing of essential pharmaceutical components. The funding comes from the US Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness
